The University of Southampton
University of Southampton Institutional Repository

Selection of novel peptides homing the 4T1 cell line: exploring alternative targets for triple negative breast cancer

Selection of novel peptides homing the 4T1 cell line: exploring alternative targets for triple negative breast cancer
Selection of novel peptides homing the 4T1 cell line: exploring alternative targets for triple negative breast cancer
The use of bacteriophages to select novel ligands has been widely explored for cancer therapy. Their application is most warranted in cancer subtypes lacking knowledge on how to target the cancer cells in question, such as the triple negative breast cancer, eventually leading to the development of alternative nanomedicines for cancer therapeutics. Therefore, the following study aimed to select and characterize novel peptides for a triple negative breast cancer murine mammary carcinoma cell line– 4T1. Using phage display, 7 and 12 amino acid random peptide libraries were screened against the 4T1 cell line. A total of four rounds, plus a counter-selection round using the 3T3 murine fibroblast cell line, was performed. The enriched selective peptides were characterized and their binding capacity towards 4T1 tissue samples was confirmed by immunofluorescence and flow cytometry analysis. The selected peptides (4T1pep1 –CPTASNTSC and 4T1pep2—EVQSSKFPAHVS) were enriched over few rounds of selection and exhibited specific binding to the 4T1 cell line. Interestingly, affinity to the human MDA-MB-231 cell line was also observed for both peptides, promoting the translational application of these novel ligands between species. Additionally, bioinformatics analysis suggested that both peptides target human Mucin-16. This protein has been implicated in different types of cancer, as it is involved in many important cellular functions. This study strongly supports the need of finding alternative targeting systems for TNBC and the peptides herein selected exhibit promising future application as novel homing peptides for breast cancer therapy.
1932-6203
Silva, Vera L
a4ac1655-f2ef-4347-a16f-4f474679b113
Ferreira, Débora
fd696bdf-78db-4dcd-b3f1-004e1c120d71
Luzia De Nobrega, Franklin
6532795d-88a4-4f05-9b26-6af5b8f21a0d
Martins, Ivone M
dda211c7-4196-4657-9375-a44699ba0b6b
Rodrigues, Lígia R
c3baa7f9-8316-4b95-b461-2b79823d862a
Kluskens, Leon D
12623693-d537-4522-8369-3cbe51f59ee3
Silva, Vera L
a4ac1655-f2ef-4347-a16f-4f474679b113
Ferreira, Débora
fd696bdf-78db-4dcd-b3f1-004e1c120d71
Luzia De Nobrega, Franklin
6532795d-88a4-4f05-9b26-6af5b8f21a0d
Martins, Ivone M
dda211c7-4196-4657-9375-a44699ba0b6b
Rodrigues, Lígia R
c3baa7f9-8316-4b95-b461-2b79823d862a
Kluskens, Leon D
12623693-d537-4522-8369-3cbe51f59ee3

Silva, Vera L, Ferreira, Débora, Luzia De Nobrega, Franklin, Martins, Ivone M, Rodrigues, Lígia R and Kluskens, Leon D (2016) Selection of novel peptides homing the 4T1 cell line: exploring alternative targets for triple negative breast cancer. PLoS ONE, 11 (8), [e0161290]. (doi:10.1371/journal.pone.016129).

Record type: Article

Abstract

The use of bacteriophages to select novel ligands has been widely explored for cancer therapy. Their application is most warranted in cancer subtypes lacking knowledge on how to target the cancer cells in question, such as the triple negative breast cancer, eventually leading to the development of alternative nanomedicines for cancer therapeutics. Therefore, the following study aimed to select and characterize novel peptides for a triple negative breast cancer murine mammary carcinoma cell line– 4T1. Using phage display, 7 and 12 amino acid random peptide libraries were screened against the 4T1 cell line. A total of four rounds, plus a counter-selection round using the 3T3 murine fibroblast cell line, was performed. The enriched selective peptides were characterized and their binding capacity towards 4T1 tissue samples was confirmed by immunofluorescence and flow cytometry analysis. The selected peptides (4T1pep1 –CPTASNTSC and 4T1pep2—EVQSSKFPAHVS) were enriched over few rounds of selection and exhibited specific binding to the 4T1 cell line. Interestingly, affinity to the human MDA-MB-231 cell line was also observed for both peptides, promoting the translational application of these novel ligands between species. Additionally, bioinformatics analysis suggested that both peptides target human Mucin-16. This protein has been implicated in different types of cancer, as it is involved in many important cellular functions. This study strongly supports the need of finding alternative targeting systems for TNBC and the peptides herein selected exhibit promising future application as novel homing peptides for breast cancer therapy.

This record has no associated files available for download.

More information

Accepted/In Press date: 27 June 2016
Published date: 22 August 2016

Identifiers

Local EPrints ID: 443074
URI: http://eprints.soton.ac.uk/id/eprint/443074
ISSN: 1932-6203
PURE UUID: bcd4ee49-8ce1-4d1b-a8e7-39ea6523435f
ORCID for Franklin Luzia De Nobrega: ORCID iD orcid.org/0000-0002-8238-1083

Catalogue record

Date deposited: 10 Aug 2020 16:30
Last modified: 17 Mar 2024 04:02

Export record

Altmetrics

Contributors

Author: Vera L Silva
Author: Débora Ferreira
Author: Ivone M Martins
Author: Lígia R Rodrigues
Author: Leon D Kluskens

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×